RE:RE:RE:RE:RE:RE:Sanofi Exploring Acquisition of KRAS Cancer Drugmaker MiratiLike I said, I welcome other thoughts, either bellow or above.
my min $1billion , max $5 billion.
My " opinion":was backed with reasonable comparable evidence.
name calling?
Not sure your motivation.
im a long term shareholder & want to see as much $$$ return as possible.
Keeping things real?
at present state.
meaning as of right now, North of $5 billion would not be justified.
add- on an accelerated approval for Pancrearic cancer....as I mentioned previously.
That would make Pela/ Roche combo a blockbuster drug.
THEN, pick a number.
In the wait time. We can wish, dream, hope, want....all we can.
The reality will be science & business based.
1. what can Pela do in a FDA approved market.
2. what will that market be worth, to the aquiring pharma.
Until #1 is answered, everything else is speculation.